1. Home
  2. ANAB vs YELP Comparison

ANAB vs YELP Comparison

Compare ANAB & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$63.70

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Yelp Inc.

YELP

Yelp Inc.

HOLD

Current Price

$28.06

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
YELP
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
ANAB
YELP
Price
$63.70
$28.06
Analyst Decision
Buy
Hold
Analyst Count
12
6
Target Price
$71.67
$29.17
AVG Volume (30 Days)
567.5K
905.8K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
91.02
19.15
EPS
N/A
2.24
Revenue
$234,603,000.00
$1,464,955,000.00
Revenue This Year
N/A
$2.19
Revenue Next Year
$52.14
$2.34
P/E Ratio
N/A
$12.40
Revenue Growth
157.01
3.75
52 Week Low
$17.11
$19.60
52 Week High
$73.30
$40.25

Technical Indicators

Market Signals
Indicator
ANAB
YELP
Relative Strength Index (RSI) 51.98 60.70
Support Level $53.46 $27.29
Resistance Level $69.56 $29.99
Average True Range (ATR) 5.32 0.87
MACD 0.01 0.03
Stochastic Oscillator 64.47 65.44

Price Performance

Historical Comparison
ANAB
YELP

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.

Share on Social Networks: